CN Patent

CN114828831A — 包含西他列汀和达格列净的复合制剂以及其制备方法

Assigned to Hanmi Pharmaceutical Co Ltd · Expires 2022-07-29 · 4y expired

What this patent protects

提供一种包含西他列汀和达格列净的复合制剂以及其制备方法。

USPTO Abstract

提供一种包含西他列汀和达格列净的复合制剂以及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114828831A
Jurisdiction
CN
Classification
—
Expires
2022-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Hanmi Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.